View source for Time-course entry page

== Overview of the time-courses == 
* Human
{|
<table border=0 cellpadding=0 cellspacing=0 width=1733 style='border-collapse:
 collapse'>
 <tr class=xl65 height=15 style='height:15.0pt'>
  <td height=15 class=xl65 width=392 style='height:15.0pt;width:392pt'>simple
  description</td>
  <td class=xl65 width=201 style='width:201pt'>cell type</td>
  <td class=xl65 width=46 style='width:46pt'>cell line</td>
  <td class=xl65 width=334 style='width:334pt'>collaborator</td>
  <td class=xl65 width=393 style='width:393pt'>experiment condition</td>
  <td class=xl69 width=149 style='width:149pt'>number donors or replicates</td>
  <td class=xl69 width=218 style='width:218pt'>number time points per donor or
  replicate</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>adipocyte differentiation</td>
  <td>adipocyte</td>
  <td></td>
  <td>Peter Arner (Karolinska Institutet)</td>
  <td>Adipocyte differentiation</td>
  <td class=xl70>4</td>
  <td class=xl70>3</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>Aortic Smooth Muscle cells treatment with
  FGF2</td>
  <td>smooth muscle cell, vascular associated</td>
  <td></td>
  <td>Levon Khachigian (University of New South Wales)</td>
  <td>Aortic smooth muscle cell response to fibroblast growth factor 2</td>
  <td class=xl70>3</td>
  <td class=xl70>10</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>Aortic Smooth Muscle cells treatment with
  IL1b</td>
  <td>smooth muscle cell, vascular associated</td>
  <td></td>
  <td>Levon Khachigian (University of New South Wales)</td>
  <td>Aortic smooth muscle cell response to interleukin 1b</td>
  <td class=xl70>3</td>
  <td class=xl70>10</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>ES cells differentiated towards
  cardiomyocyte</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
  <td>Christine Mummery/Robert Passier</td>
  <td></td>
  <td class=xl70>3</td>
  <td class=xl70>12</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>H9 Embryoid body cells after melanocytic
  induction</td>
  <td>stem cell/ unclassifiable</td>
  <td>H9</td>
  <td>Susan Zabierowski (Wistar Institute)</td>
  <td>Human ES cell differentiation to melanocyte</td>
  <td class=xl70>3</td>
  <td class=xl70>14</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>H9 Embryonic Stem cell</td>
  <td>stem cell</td>
  <td>H9</td>
  <td>Susan Zabierowski (Wistar Institute)</td>
  <td>Human ES cell differentiation to melanocyte</td>
  <td class=xl70>3</td>
  <td class=xl70>1</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>K562 erythroblastic leukemia line</td>
  <td>erythroblast</td>
  <td>K562</td>
  <td>Peter Klinken (Western Australian Institute of Medical Research)</td>
  <td>K562 erythroblastic leukemia response to hemin</td>
  <td class=xl70>3</td>
  <td class=xl71>18</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>Lymphatic Endothelial cells</td>
  <td>endothelial cell, lymphatic</td>
  <td></td>
  <td>Michael Detmar (Swiss Federal Institute of Technology, ETH Zurich)</td>
  <td>Lymphatic Endothelial cells response to Vascular endothelial growth
  factor C</td>
  <td class=xl70>3</td>
  <td class=xl70>16</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>MCF7 breast cancer cell line EFG1
  treatment</td>
  <td>mammary gland epithelial cell</td>
  <td>MCF7</td>
  <td>Mariko Okada Hatakeyama (RIKEN RCAI)</td>
  <td>MCF7 breast cancer cell line response to Epidermal Growth Factor 1</td>
  <td class=xl70>3</td>
  <td class=xl71>16</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>MCF7 breast cancer cell line HRG
  treatment</td>
  <td>mammary gland epithelial cell</td>
  <td>MCF7</td>
  <td>Mariko Okada Hatakeyama (RIKEN RCAI)</td>
  <td>MCF7 breast cancer cell line response to Heregulin</td>
  <td class=xl70>3</td>
  <td class=xl71>16</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>Melanocyte</td>
  <td>melanocyte</td>
  <td></td>
  <td>Susan Zabierowski (Wistar Institute)</td>
  <td>Human ES cell differentiation to melanocyte</td>
  <td class=xl70>3</td>
  <td class=xl70>1</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 class=xl66 style='height:15.0pt'>mesenchymal stem cells
  adipogenic induction</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
  <td>Peter Arner(Karolinska)</td>
  <td></td>
  <td class=xl70>3</td>
  <td class=xl70>17</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 class=xl66 style='height:15.0pt'>mesenchymal stem cells
  (adipose derived) untreated control replicate1</td>
  <td>SELECT CELL TYPE</td>
  <td></td>
  <td>Peter Arner(Karolinska)</td>
  <td></td>
  <td class=xl70>3</td>
  <td class=xl70>1</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>Monocyte-derived macrophages mock
  infection</td>
  <td>HMDM</td>
  <td>primary</td>
  <td>Baillie/Tomoiu/Fisher/Hume</td>
  <td>MI</td>
  <td class=xl70>4</td>
  <td class=xl70>2</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>Monocyte-derived macrophages udorn
  influenza infection</td>
  <td>HMDM</td>
  <td>primary</td>
  <td>Baillie/Tomoiu/Fisher/Hume</td>
  <td>Ud</td>
  <td class=xl70>4</td>
  <td class=xl70>4</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>Monocyte-derived macrophages LPS
  treatment</td>
  <td>macrophage</td>
  <td></td>
  <td>Kenneth Baillie (Roslin Institute)</td>
  <td>Monocyte derived macrophages repsonse to LPS</td>
  <td class=xl70>5</td>
  <td class=xl70>26</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 class=xl67 style='height:15.0pt'>Saos-2 osteosarcoma cell line
  induction of calcification with ascorbate and BPG</td>
  <td>osteoblast</td>
  <td></td>
  <td>Kim Summers (Roslin Institute)</td>
  <td>Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce
  calcification</td>
  <td class=xl70>3</td>
  <td class=xl70>18</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 class=xl67 style='height:15.0pt'>Saos-2 osteosarcoma cell line
  0min untreated control</td>
  <td>osteoblast</td>
  <td>Saos-2</td>
  <td>Kim Summers (Roslin Institute)</td>
  <td>Saos-2 osteosarcoma untreated control</td>
  <td class=xl70>3</td>
  <td class=xl70>18</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 class=xl66 style='height:15.0pt'>UH-1</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
  <td>Christine Mummery/Robert Passier</td>
  <td></td>
  <td class=xl70>1</td>
  <td class=xl70>1</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 class=xl66 style='height:15.0pt'>UH-2</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
  <td>Christine Mummery/Robert Passier</td>
  <td></td>
  <td class=xl70>1</td>
  <td class=xl70>1</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 class=xl66 style='height:15.0pt'>UH-3</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
  <td>Christine Mummery/Robert Passier</td>
  <td></td>
  <td class=xl70>1</td>
  <td class=xl70>1</td>
 </tr>
</table>
|}

* Mouse
{|
<table border=0 cellpadding=0 cellspacing=0 width=1611 style='border-collapse:
 collapse'>
 <tr class=xl65 height=15 style='height:15.0pt'>
  <td height=15 class=xl65 width=361 style='height:15.0pt;width:361pt'>simple
  description</td>
  <td class=xl65 width=121 style='width:121pt'>cell type</td>
  <td class=xl65 width=55 style='width:55pt'>cell line</td>
  <td class=xl65 width=322 style='width:322pt'>collaborator</td>
  <td class=xl65 width=385 style='width:385pt'>experiment condition</td>
  <td class=xl69 width=149 style='width:149pt'>number donors or replicates</td>
  <td class=xl69 width=218 style='width:218pt'>number time points per donor or
  replicate</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>EBF KO HPCs induced to T cell 0.5h
  replicate 1</td>
  <td>unclassifiable</td>
  <td></td>
  <td>Tomokatsu Ikawa (RCAI)</td>
  <td>T cell differentiation</td>
  <td class=xl70>3</td>
  <td class=xl70>15</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>J2E erythroblastic leukemia line
  treatment with erythropoietin</td>
  <td>erythroblast</td>
  <td>J2E</td>
  <td>Peter Klinken (Western Australian Institute of Medical Research)</td>
  <td>J2E erythroblastic leukemia response to erythropoietin</td>
  <td class=xl70>3</td>
  <td class=xl70>16</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>ST2 (Mesenchymal stem cells) cells<span
  style="mso-spacerun:yes">&nbsp; </span>medium change (without induction)<span
  style="mso-spacerun:yes">&nbsp;</span></td>
  <td>mesenchymal stem cell</td>
  <td>ST2</td>
  <td>Yasushi Okazaki (Saitama medical college)</td>
  <td>ST2 mesenchymal stem cell differentiation medium change untreated control</td>
  <td class=xl70>3</td>
  <td class=xl70>10</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>ST2 (Mesenchymal stem cells) cells
  adipogenic induction</td>
  <td>mesenchymal stem cell</td>
  <td>ST2</td>
  <td>Yasushi Okazaki (Saitama medical college)</td>
  <td>ST2 mesenchymal stem cell differentiation to adipocytes</td>
  <td class=xl70>3</td>
  <td class=xl70>15</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>ST2 (Mesenchymal stem cells) cells
  osteogenic induction</td>
  <td>mesenchymal stem cell</td>
  <td>ST2</td>
  <td>Yasushi Okazaki (Saitama medical college)</td>
  <td>ST2 mesenchymal stem cell differentiation to osteocytes</td>
  <td class=xl70>3</td>
  <td class=xl70>15</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>tracheal ciliated cells differentiation</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
  <td>Mitsuru Morimoto</td>
  <td></td>
  <td class=xl70>3</td>
  <td class=xl70>18</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 class=xl68 style='height:15.0pt'>trophoblast stem cell line B1
  0 days after differentiation</td>
  <td></td>
  <td></td>
  <td>Hirohiko Kodeki(RCAI)</td>
  <td></td>
  <td class=xl70>3</td>
  <td class=xl70>6</td>
 </tr>
 <tr height=15 style='height:15.0pt'>
  <td height=15 style='height:15.0pt'>TSt-4/DLL1 feeder cells</td>
  <td>unclassifiable</td>
  <td></td>
  <td>Tomokatsu Ikawa (RCAI)</td>
  <td>T cell differentiation</td>
  <td class=xl70>3</td>
  <td class=xl70>1</td>
 </tr>
</table>
|}

== Relate material ==
* Time-courses kick-off presentation at the regular FANTOM5 teleconference call